- Home
- ORKT vs LSTA Comparison
ORKT vs LSTA Comparison
Compare ORKT & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKT
- LSTA
- Stock Information
- Founded
- ORKT 2003
- LSTA 1980
- Country
- ORKT Singapore
- LSTA United States
- Employees
- ORKT N/A
- LSTA N/A
- Industry
- ORKT
- LSTA Misc Health and Biotechnology Services
- Sector
- ORKT
- LSTA Health Care
- Exchange
- ORKT NYSE
- LSTA Nasdaq
- Market Cap
- ORKT N/A
- LSTA 20.9M
- IPO Year
- ORKT 2024
- LSTA N/A
- Fundamental
- Price
- ORKT $0.55
- LSTA $2.73
- Analyst Decision
- ORKT Strong Buy
- LSTA Strong Buy
- Analyst Count
- ORKT 1
- LSTA 1
- Target Price
- ORKT $5.00
- LSTA $15.00
- AVG Volume (30 Days)
- ORKT 254.6K
- LSTA 15.4K
- Earning Date
- ORKT 01-01-0001
- LSTA 08-11-2025
- Dividend Yield
- ORKT N/A
- LSTA N/A
- EPS Growth
- ORKT N/A
- LSTA N/A
- EPS
- ORKT N/A
- LSTA N/A
- Revenue
- ORKT $2,962,282.00
- LSTA $1,000,000.00
- Revenue This Year
- ORKT $9.63
- LSTA N/A
- Revenue Next Year
- ORKT N/A
- LSTA N/A
- P/E Ratio
- ORKT N/A
- LSTA N/A
- Revenue Growth
- ORKT N/A
- LSTA N/A
- 52 Week Low
- ORKT $0.40
- LSTA $1.87
- 52 Week High
- ORKT $8.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- ORKT N/A
- LSTA 54.95
- Support Level
- ORKT N/A
- LSTA $2.36
- Resistance Level
- ORKT N/A
- LSTA $3.07
- Average True Range (ATR)
- ORKT 0.00
- LSTA 0.22
- MACD
- ORKT 0.00
- LSTA 0.03
- Stochastic Oscillator
- ORKT 0.00
- LSTA 52.78
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.